Mol Med Rep:环肽改性支架可用于组织工程骨修复

2019-07-28 不详 网络

股骨头坏死(ONFH)是一种常见的骨病。在股骨头塌陷之前治疗ONFH对于提高治疗效率是至关重要的。使用骨髓间充质干细胞(BMSCs)与支架结合的组织工程疗法是一种很有前景的策略。但是,目前尚不清楚如何在这种条件下提高BMSC募集的效率。在本研究中,使用用于Sprague-Dawley大鼠BMSC的特定环肽,CTTNPFSLC(称为C7),其通过噬菌体展示技术鉴定。使用流式细胞术和荧光染色证明其对B

股骨头坏死(ONFH)是一种常见的骨病。在股骨头塌陷之前治疗ONFH对于提高治疗效率是至关重要的。使用骨髓间充质干细胞(BMSCs)与支架结合的组织工程疗法是一种很有前景的策略。但是,目前尚不清楚如何在这种条件下提高BMSC募集的效率。

在本研究中,使用用于Sprague-Dawley大鼠BMSC的特定环肽,CTTNPFSLC(称为C7),其通过噬菌体展示技术鉴定。使用流式细胞术和荧光染色证明其对BMSC的高亲和力。随后,使用吸收和冷冻干燥过程将环肽置于β-磷酸三钙(β-TCP)支架上。在C7处理的β-TCP支架上体外研究BMSC的粘附,扩增和增殖,并与纯β-TCP支架进行比较。结果显示,C7对β-TCP支架上BMSCs的粘附,扩增和增殖具有促进作用。

总之,该研究结果表明,C7可能在将来的ONFH组织工程治疗中有效。

原始出处:

Sun T, Man Z, et al., A specific affinity cyclic peptide enhances the adhesion, expansion and proliferation of rat bone mesenchymal stem cells on β tricalcium phosphate scaffolds. Mol Med Rep. 2019 Aug;20(2):1157-1166. doi: 10.3892/mmr.2019.10335. Epub 2019 Jun 4.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1719500, encodeId=89901e195003b, content=<a href='/topic/show?id=17641015914f' target=_blank style='color:#2F92EE;'>#骨修复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101591, encryptionId=17641015914f, topicName=骨修复)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5232746261, createdName=axin020, createdTime=Tue Aug 27 10:03:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417199, encodeId=734f141e199b6, content=<a href='/topic/show?id=8b72e769056' target=_blank style='color:#2F92EE;'>#组织工程#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77690, encryptionId=8b72e769056, topicName=组织工程)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c62f3243688, createdName=zhu_jun9838, createdTime=Tue Jul 30 10:03:00 CST 2019, time=2019-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609889, encodeId=8de11609889f9, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Tue Jul 30 10:03:00 CST 2019, time=2019-07-30, status=1, ipAttribution=)]
    2019-08-27 axin020
  2. [GetPortalCommentsPageByObjectIdResponse(id=1719500, encodeId=89901e195003b, content=<a href='/topic/show?id=17641015914f' target=_blank style='color:#2F92EE;'>#骨修复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101591, encryptionId=17641015914f, topicName=骨修复)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5232746261, createdName=axin020, createdTime=Tue Aug 27 10:03:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417199, encodeId=734f141e199b6, content=<a href='/topic/show?id=8b72e769056' target=_blank style='color:#2F92EE;'>#组织工程#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77690, encryptionId=8b72e769056, topicName=组织工程)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c62f3243688, createdName=zhu_jun9838, createdTime=Tue Jul 30 10:03:00 CST 2019, time=2019-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609889, encodeId=8de11609889f9, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Tue Jul 30 10:03:00 CST 2019, time=2019-07-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1719500, encodeId=89901e195003b, content=<a href='/topic/show?id=17641015914f' target=_blank style='color:#2F92EE;'>#骨修复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101591, encryptionId=17641015914f, topicName=骨修复)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5232746261, createdName=axin020, createdTime=Tue Aug 27 10:03:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417199, encodeId=734f141e199b6, content=<a href='/topic/show?id=8b72e769056' target=_blank style='color:#2F92EE;'>#组织工程#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77690, encryptionId=8b72e769056, topicName=组织工程)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c62f3243688, createdName=zhu_jun9838, createdTime=Tue Jul 30 10:03:00 CST 2019, time=2019-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609889, encodeId=8de11609889f9, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Tue Jul 30 10:03:00 CST 2019, time=2019-07-30, status=1, ipAttribution=)]